Top Regulatory News Stories – Week Ending January 19, 2018
This was a relatively quiet week for regulatory news. Here is my summary of the top regulatory stories in pharma and biotech: The FDA provided draft guidance regarding a new program which will expand Priority Review Vouchers for medical countermeasure programs including therapeutics and prophylactics for conditions linked with chemical, biological, radiological and nuclear threats,[…]